Can pheochromocytoma cause panic attacks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pheochromocytoma and Panic Attacks: The Connection

Yes, pheochromocytoma can cause symptoms that mimic or present as panic attacks due to the episodic release of catecholamines that trigger paroxysmal symptoms similar to anxiety disorders. 1, 2

Pathophysiological Mechanism

  • Pheochromocytomas are catecholamine-producing tumors that cause episodic or sustained release of norepinephrine and epinephrine 1
  • These catecholamines act on alpha and beta-adrenergic receptors throughout the body, causing symptoms that can closely resemble panic attacks 2
  • The increased blood pressure variability characteristic of pheochromocytoma constitutes an independent risk factor for cardiovascular morbidity and mortality beyond the increased blood pressure itself 1

Clinical Presentation

  • Approximately 95% of patients with pheochromocytoma present with hypertension, with 50% having sustained hypertension and 50% having paroxysmal (episodic) hypertension 2
  • The classic triad of symptoms includes:
    • Headaches
    • Palpitations
    • Sweating
  • This triad, when occurring in an episodic fashion, has a diagnostic specificity of 90% 1
  • Additional symptoms that overlap with panic attacks include:
    • Anxiety
    • Tremor
    • Pallor
    • Diaphoresis ("cold sweat")
    • Tachycardia 1, 3

Differentiating from True Panic Disorder

  • Despite the similarity in symptoms, research shows that the elevated catecholamines from pheochromocytomas are not always sufficient to elicit a true anxiety disorder 4
  • In a study of 17 patients with active pheochromocytoma, only one received a diagnosis of possible panic disorder, and none described the severe apprehension or fear characteristic of panic attacks 4
  • The term "pseudopheochromocytoma" has been used to describe paroxysmal hypertension without significantly elevated catecholamine concentrations, which can occur in patients with anxiety disorders 5

Diagnostic Considerations

  • Pheochromocytoma should be considered in any patient with:
    • Paroxysmal hypertension
    • Resistant hypertension
    • Hypertension with the classic triad of symptoms
    • Apparent panic attacks with concurrent hypertension 1
  • The best screening test for pheochromocytoma is plasma free metanephrines (normetanephrine and metanephrine), which carries a 99% sensitivity and an 89% specificity 1, 2
  • If plasma testing is equivocal (less than fourfold elevation), a 24-hour urine collection for catecholamines and metanephrines should be performed 1, 2

Clinical Pitfalls

  • Despite improved diagnostic techniques, there remains an average of 3 years between initial symptoms and final diagnosis of pheochromocytoma 1, 2
  • Many cases are missed altogether, with autopsy studies showing that pheochromocytomas contributed to 55% of deaths and were not suspected in 75% of cases 1, 2
  • Pheochromocytoma can be mistaken for:
    • Panic disorder
    • Generalized anxiety disorder
    • Essential hypertension
    • Migraine headaches
    • Cardiac arrhythmias 3, 6

Management Implications

  • Once diagnosed, pheochromocytoma requires proper preoperative medical management:
    • Alpha-adrenergic blockade must be initiated at least 7-14 days before surgery 7
    • Beta-blockers should ONLY be added after adequate alpha blockade to control tachyarrhythmias 7
    • Monotherapy with beta-blockers can elicit hypertension and is contraindicated 1
  • Surgical resection is the definitive treatment for pheochromocytoma 7

Conclusion

When evaluating patients with apparent panic attacks, especially those with concurrent hypertension or other atypical features, clinicians should consider pheochromocytoma in the differential diagnosis. The overlap in symptoms between pheochromocytoma and panic disorder makes this distinction clinically important, as missing the diagnosis of pheochromocytoma can lead to significant morbidity and mortality.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pheochromocytoma Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anxiety in patients with pheochromocytomas.

Archives of internal medicine, 1985

Research

Pseudopheochromocytoma induced by anxiolytic withdrawal.

European journal of medical research, 2014

Guideline

Initial Treatment for Pheochromocytoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.